MicroRNA-345 induces apoptosis in pancreatic cancer cells through potentiation of caspase-dependent and -independent pathways

British Journal of Cancer

Volumn 113, Issue 4, 2015, Pages 660-668

  Srivastava, Sanjeev K ^a   Bhardwaj, Arun ^a   Arora, Sumit ^a   Tyagi, Nikhil ^a   Singh, Seema ^a   Andrews, Joel ^a   Mcclellan, Steve ^a   Wang, Bin ^a   Singh, Ajay P ^a,b  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

^b UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

apoptosis; BCL2; MIR 345; mitochondrial membrane potential; pancreatic cancer

Indexed keywords

APOPTOSIS INDUCING FACTOR; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 3; CASPASE 7; CASPASE 9; CYTOCHROME C; EFFECTOR CASPASE; HOE 33342; LIPOCORTIN 5; MICRORNA; MICRORNA 345; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN BCL 2; UNCLASSIFIED DRUG; MIRN345 MICRORNA, HUMAN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PARP1 PROTEIN, HUMAN; PROTEIN BAX;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CELL FRACTIONATION; CELL GROWTH; CELL PROLIFERATION; CHROMATIN CONDENSATION; CONTROLLED STUDY; CYTOSOL; DOWN REGULATION; ENZYME ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MITOCHONDRIAL MEMBRANE POTENTIAL; MUTATIONAL ANALYSIS; PANCREATIC CANCER CELL LINE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN RNA BINDING; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STABLE TRANSFECTION; UPREGULATION; WST-1 ASSAY; CELL NUCLEUS; GENE EXPRESSION REGULATION; GENETICS; MITOCHONDRION; PANCREAS TUMOR; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASE 7; CELL LINE, TUMOR; CELL NUCLEUS; CYTOCHROMES C; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICRORNAS; MITOCHONDRIA; PANCREATIC NEOPLASMS; POLY(ADP-RIBOSE) POLYMERASES; SIGNAL TRANSDUCTION;

EID: 84939252612     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2015.252     Document Type: Article

References (42)

1. Arora S, Bhardwaj A, Singh S, Srivastava SK, McClellan S, Nirodi CS, Piazza GA, Grizzle WE, Owen LB, Singh AP. (2013). An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through reactive oxygen species-dependent, nuclear factor kappaB- And hypoxia-inducible factor 1alpha-mediated up-regulation of CXCR4. J Biol Chem. 288(29): 21197-21207.
2. Arora S, Tyagi N, Bhardwaj A, Rusu L, Palanki R, Vig K, Singh SR, Singh AP, Palanki S, Miller ME, Carter JE, Singh S. (2015). Silver nanoparticles protect human keratinocytes against UVB radiation-induced DNA damage and apoptosis: potential for prevention of skin carcinogenesis. Nanomedicine. 11(5): 1265-1275.
3. Bauer C, Hees C, Sterzik A, Bauernfeind F, Mak'Anyengo R, Duewell P, Lehr HA, Noessner E, Wank R, Trauzold A, Endres S, Dauer M, Schnurr M. (2015). Proapoptotic and Antiapoptotic Proteins of the Bcl-2 Family Regulate Sensitivity of Pancreatic Cancer Cells Toward Gemcitabine and T-Cellmediated Cytotoxicity. J Immunother. 38(3): 116-126.
4. Bhardwaj A, Singh S, Singh AP. (2010). MicroRNA-based cancer therapeutics: big hope from small RNAs. Mol Cell Pharmacol. 2(5): 213-219.
5. Bhardwaj A, Srivastava SK, Singh S, Arora S, Tyagi N, Andrews J, McClellan S, Carter JE, Singh AP. (2014). CXCL12/CXCR4 signaling counteracts docetaxel-induced microtubule stabilization via p21-Activated kinase. 4-dependent activation of LIM domain kinase 1. Oncotarget. 5(22): 11490-11500.
6. Bhat TA, Kumar S, Chaudhary AK, Yadav N, Chandra D. (2015). Restoration of mitochondria function as a target for cancer therapy. Drug Discov Today. 20(5): 635-643.
7. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C, Croce CM. (2007). MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA. 297(17): 1901-1908
8. Bold RJ, Chandra J, McConkey DJ. (1999). Gemcitabine-induced programmed cell death (apoptosis) of human pancreatic carcinoma is determined by Bcl-2 content. Ann Surg Oncol. 6(3): 279-285.
9. Bold RJ, Virudachalam S, McConkey DJ. (2001). BCL2 expression correlates with metastatic potential in pancreatic cancer cell lines. Cancer. 92(5): 1122-1129.
10. Borner C, Monney L. (1999). Apoptosis without caspases: an inefficient molecular guillotine?. Cell Death Differ. 6(6): 497-507.
11. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM. (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA. 101(9): 2999-3004.
12. Campbell PM, Lee KM, Ouellette MM, Kim HJ, Groehler AL, Khazak V, Der CJ. (2008). Ras-driven transformation of human nestin-positive pancreatic epithelial cells. Methods Enzymol. 439: 451-465.
13. Cande C, Vahsen N, Garrido C, Kroemer G. (2004). Apoptosis-inducing factor (AIF): caspase-independent after all. Cell Death Differ. 11(6): 591-595.
14. Deshmukh SK, Srivastava SK, Bhardwaj A, Singh AP, Tyagi N, Marimuthu S, Dyess DL, Zotto VD, Carter JE, Singh S. (2015). Resistin and interleukin-6 exhibit racially-disparate expression in breast cancer patients, display molecular association and promote growth and aggressiveness of tumor cells through STAT3 activation. Oncotarget. 6(13): 11231-11241.
15. Elkholi R, Renault TT, Serasinghe MN, Chipuk JE. (2014). Putting the Pieces Together: How Is the Mitochondrial Pathway of Apoptosis Regulated in Cancer and Chemotherapy?. Cancer Metab. 6: 2-16.
16. Elmore S. (2007). Apoptosis: a review of programmed cell death. Toxicol Pathol. 35(4): 495-516.
17. Feldmann G, Maitra A. (2008). Molecular genetics of pancreatic ductal adenocarcinomas and recent implications for translational efforts. J Mol Diagn. 10(2): 111-122.
18. Friedlander MR, Lizano E, Houben AJ, Bezdan D, Banez-Coronel M, Kudla G, Mateu-Huertas E, Kagerbauer B, Gonzalez J, Chen KC, LeProust EM, Marti E, Estivill X. (2014). Evidence for the biogenesis of more than 1, 000 novel human microRNAs. Genome Biol. 15(4): R57-15.
19. Guo Y, Ziesch A, Hocke S, Kampmann E, Ochs S, De Toni EN, Goke B, Gallmeier E. (2015). Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis. J Cell Mol Med. 19(2): 340-350.
20. Gupta S, Kass GE, Szegezdi E, Joseph B. (2009). The mitochondrial death pathway: a promising therapeutic target in diseases. J Cell Mol Med. 13(6): 1004-1033.
21. Harris MH, Thompson CB. (2000). The role of the Bcl-2 family in the regulation of outer mitochondrial membrane permeability. Cell Death Differ. 7(12): 1182-1191.
22. Lee EJ, Gusev Y, Jiang J, Nuovo GJ, Lerner MR, Frankel WL, Morgan DL, Postier RG, Brackett DJ, Schmittgen TD. (2007). Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer. 120(5): 1046-1054.
23. Loukopoulos P, Shibata T, Katoh H, Kokubu A, Sakamoto M, Yamazaki K, Kosuge T, Kanai Y, Hosoda F, Imoto I, Ohki M, Inazawa J, Hirohashi S. (2007). Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: identification of genetic indicators that predict patient outcome. Cancer Sci. 98(3): 392-400.
24. Lu J, Clark AG. (2012). Impact of microRNA regulation on variation in human gene expression. Genome Res. 22(7): 1243-1254.
25. Pogribny IP, Filkowski JN, Tryndyak VP, Golubov A, Shpyleva SI, Kovalchuk O. (2010). Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin. Int J Cancer. 127(8): 1785-1794.
26. Ryan BM, Robles AI, Harris CC. (2010). Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer. 10(6): 389-402.
27. Scherr M, Elder A, Battmer K, Barzan D, Bomken S, Ricke-Hoch M, Schroder A, Venturini L, Blair HJ, Vormoor J, Ottmann O, Ganser A, Pich A, Hilfiker-Kleiner D, Heidenreich O, Eder M. (2014). Differential expression of miR-17B92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemia. Leukemia. 28(3): 554-565.
28. Siegel RL, Miller KD, Jemal A. (2015). Cancer statistics, 2015. CA Cancer J Clin. 65(1): 5-29.
29. Sperandio S, de Belle I, Bredesen DE. (2000). An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci USA. 97(26): 14376-14381.
30. Srivastava SK, Arora S, Singh S, Bhardwaj A, Averett C, Singh AP. (2014). MicroRNAs in pancreatic malignancy: progress and promises. Cancer Lett. 347(2): 167-174.
31. Srivastava SK, Bhardwaj A, Leavesley SJ, Grizzle WE, Singh S, Singh AP. (2013). MicroRNAs as potential clinical biomarkers: emerging approaches for their detection. Biotech Histochem. 88(7): 373-387.
32. Srivastava SK, Bhardwaj A, Singh S, Arora S, McClellan S, Grizzle WE, Reed E, Singh AP. (2012). Myb overexpression overrides androgen depletioninduced cell cycle arrest and apoptosis in prostate cancer cells, and confers aggressive malignant traits: potential role in castration resistance. Carcinogenesis. 33(6): 1149-1157.
33. Srivastava SK, Bhardwaj A, Singh S, Arora S, Wang B, Grizzle WE, Singh AP. (2011). MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells. Carcinogenesis. 32(12): 1832-1839.
34. Sun CY, Wang BL, Hu CQ, Peng RY, Gao YB, Gu QY, Wang DW. (2002). Expression of the bcl-2 gene and its significance in human pancreatic carcinoma. Hepatobiliary Pancreat Dis Int. 1(2): 306-308.
35. Susin SA, Zamzami N, Castedo M, Hirsch T, Marchetti P, Macho A, Daugas E, Geuskens M, Kroemer G. (1996). Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med. 184(4): 1331-1341.
36. Susin SA, Zamzami N, Kroemer G. (1998). Mitochondria as regulators of apoptosis: doubt no more. Biochim Biophys Acta. 1366(1-2): 151-165.
37. Szafranska AE, Davison TS, John J, Cannon T, Sipos B, Maghnouj A, Labourier E, Hahn SA. (2007). MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene. 26(30): 4442-4452.
38. Tait SW, Green DR. (2010). Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol. 11(9): 621-632.
39. Tang JT, Wang JL, Du W, Hong J, Zhao SL, Wang YC, Xiong H, Chen HM, Fang JY. (2011). MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer. Carcinogenesis. 32(8): 1207-1215.
40. Tyagi N, Bhardwaj A, Singh AP, McClellan S, Carter JE, Singh S. (2014). p-21 activated kinase 4 promotes proliferation and survival of pancreatic cancer cells through AKT- And ERK-dependent activation of NF-kappaB pathway. Oncotarget. 5(18): 8778-8789.
41. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X. (1997). Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275(5303): 1129-1132.
42. Zearo S, Kim E, Zhu Y, Zhao JT, Sidhu SB, Robinson BG, Soon PS. (2014). MicroRNA-484 is more highly expressed in serum of early breast cancer patients compared to healthy volunteers. BMC Cancer. 14: 200-214.